1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chill, J.H. Quadt, S.R. Levy, R. Schreiber, G. Anglister, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 11 791 802 10.1016/S0969-2126(03)00120-5 12842042 The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding. 2003 US Biochemistry BICHAW 0033 0006-2960 41 3575 3585 10.1021/bi011778f The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha2 binding site, and observed ligand-induced tightening 2002 10.2210/pdb1n6v/pdb pdb_00001n6v 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 24323.438 Interferon-alpha/beta receptor beta chain 1 man polymer IFNAR2-EC, IFN-alpha-REC, Type I interferon receptor, IFN-R, Interferon alpha/beta receptor- 2 no no SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESEFS SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESEFS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli TG1 PLASMID database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-07-15 1 1 2008-04-28 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details RCSB Y RCSB 2002-11-12 REL REL All experiments conducted in Shigemi tubes equipped with insert 1 3D_15N-separated_NOESY HNHA HNCA HNCACB CBCACONH 3D_13C-separated_NOESY 20mM Tris buffer 8 ambient 308 K 20mM Tris buffer 8 ambient 308 K 20mM Tris buffer 8 ambient 305 K Structure based upon 1947 NOE-derived distance restraints (1066 of which long range), 172 dihedral angle restraints (of which 88 experimental and 84 TALOS-derived), 138 hydrogen-bond restraints and 109 residual dipolar coupling restraints distance geometry, simulated annealing 1 minimized average structure 0.4mM U-15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3 95% H2O/5% D2O 0.35mM U-13C,15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3 95% H2O/5% D2O 0.3mM U-13C,15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3 99% D2O Neidig processing XwinNMR 3.0 Brunger structure solution CNS 1.1 Delaglio data analysis NMRPipe 2.1 Brunger refinement CNS 1.1 800 Bruker DRX 500 Bruker DMX SER 1 n 1 SER 1 A TYR 2 n 2 TYR 2 A ASP 3 n 3 ASP 3 A SER 4 n 4 SER 4 A PRO 5 n 5 PRO 5 A ASP 6 n 6 ASP 6 A TYR 7 n 7 TYR 7 A THR 8 n 8 THR 8 A ASP 9 n 9 ASP 9 A GLU 10 n 10 GLU 10 A SER 11 n 11 SER 11 A CYS 12 n 12 CYS 12 A THR 13 n 13 THR 13 A PHE 14 n 14 PHE 14 A LYS 15 n 15 LYS 15 A ILE 16 n 16 ILE 16 A SER 17 n 17 SER 17 A LEU 18 n 18 LEU 18 A ARG 19 n 19 ARG 19 A ASN 20 n 20 ASN 20 A PHE 21 n 21 PHE 21 A ARG 22 n 22 ARG 22 A SER 23 n 23 SER 23 A ILE 24 n 24 ILE 24 A LEU 25 n 25 LEU 25 A SER 26 n 26 SER 26 A TRP 27 n 27 TRP 27 A GLU 28 n 28 GLU 28 A LEU 29 n 29 LEU 29 A LYS 30 n 30 LYS 30 A ASN 31 n 31 ASN 31 A HIS 32 n 32 HIS 32 A SER 33 n 33 SER 33 A ILE 34 n 34 ILE 34 A VAL 35 n 35 VAL 35 A PRO 36 n 36 PRO 36 A THR 37 n 37 THR 37 A HIS 38 n 38 HIS 38 A TYR 39 n 39 TYR 39 A THR 40 n 40 THR 40 A LEU 41 n 41 LEU 41 A LEU 42 n 42 LEU 42 A TYR 43 n 43 TYR 43 A THR 44 n 44 THR 44 A ILE 45 n 45 ILE 45 A MET 46 n 46 MET 46 A SER 47 n 47 SER 47 A LYS 48 n 48 LYS 48 A PRO 49 n 49 PRO 49 A GLU 50 n 50 GLU 50 A ASP 51 n 51 ASP 51 A LEU 52 n 52 LEU 52 A LYS 53 n 53 LYS 53 A VAL 54 n 54 VAL 54 A VAL 55 n 55 VAL 55 A LYS 56 n 56 LYS 56 A ASN 57 n 57 ASN 57 A CYS 58 n 58 CYS 58 A ALA 59 n 59 ALA 59 A ASN 60 n 60 ASN 60 A THR 61 n 61 THR 61 A THR 62 n 62 THR 62 A ARG 63 n 63 ARG 63 A SER 64 n 64 SER 64 A PHE 65 n 65 PHE 65 A CYS 66 n 66 CYS 66 A ASP 67 n 67 ASP 67 A LEU 68 n 68 LEU 68 A THR 69 n 69 THR 69 A ASP 70 n 70 ASP 70 A GLU 71 n 71 GLU 71 A TRP 72 n 72 TRP 72 A ARG 73 n 73 ARG 73 A SER 74 n 74 SER 74 A THR 75 n 75 THR 75 A HIS 76 n 76 HIS 76 A GLU 77 n 77 GLU 77 A ALA 78 n 78 ALA 78 A TYR 79 n 79 TYR 79 A VAL 80 n 80 VAL 80 A THR 81 n 81 THR 81 A VAL 82 n 82 VAL 82 A LEU 83 n 83 LEU 83 A GLU 84 n 84 GLU 84 A GLY 85 n 85 GLY 85 A PHE 86 n 86 PHE 86 A SER 87 n 87 SER 87 A GLY 88 n 88 GLY 88 A ASN 89 n 89 ASN 89 A THR 90 n 90 THR 90 A THR 91 n 91 THR 91 A LEU 92 n 92 LEU 92 A PHE 93 n 93 PHE 93 A SER 94 n 94 SER 94 A CYS 95 n 95 CYS 95 A SER 96 n 96 SER 96 A HIS 97 n 97 HIS 97 A ASN 98 n 98 ASN 98 A PHE 99 n 99 PHE 99 A TRP 100 n 100 TRP 100 A LEU 101 n 101 LEU 101 A ALA 102 n 102 ALA 102 A ILE 103 n 103 ILE 103 A ASP 104 n 104 ASP 104 A MET 105 n 105 MET 105 A SER 106 n 106 SER 106 A PHE 107 n 107 PHE 107 A GLU 108 n 108 GLU 108 A PRO 109 n 109 PRO 109 A PRO 110 n 110 PRO 110 A GLU 111 n 111 GLU 111 A PHE 112 n 112 PHE 112 A GLU 113 n 113 GLU 113 A ILE 114 n 114 ILE 114 A VAL 115 n 115 VAL 115 A GLY 116 n 116 GLY 116 A PHE 117 n 117 PHE 117 A THR 118 n 118 THR 118 A ASN 119 n 119 ASN 119 A HIS 120 n 120 HIS 120 A ILE 121 n 121 ILE 121 A ASN 122 n 122 ASN 122 A VAL 123 n 123 VAL 123 A MET 124 n 124 MET 124 A VAL 125 n 125 VAL 125 A LYS 126 n 126 LYS 126 A PHE 127 n 127 PHE 127 A PRO 128 n 128 PRO 128 A SER 129 n 129 SER 129 A ILE 130 n 130 ILE 130 A VAL 131 n 131 VAL 131 A GLU 132 n 132 GLU 132 A GLU 133 n 133 GLU 133 A GLU 134 n 134 GLU 134 A LEU 135 n 135 LEU 135 A GLN 136 n 136 GLN 136 A PHE 137 n 137 PHE 137 A ASP 138 n 138 ASP 138 A LEU 139 n 139 LEU 139 A SER 140 n 140 SER 140 A LEU 141 n 141 LEU 141 A VAL 142 n 142 VAL 142 A ILE 143 n 143 ILE 143 A GLU 144 n 144 GLU 144 A GLU 145 n 145 GLU 145 A GLN 146 n 146 GLN 146 A SER 147 n 147 SER 147 A GLU 148 n 148 GLU 148 A GLY 149 n 149 GLY 149 A ILE 150 n 150 ILE 150 A VAL 151 n 151 VAL 151 A LYS 152 n 152 LYS 152 A LYS 153 n 153 LYS 153 A HIS 154 n 154 HIS 154 A LYS 155 n 155 LYS 155 A PRO 156 n 156 PRO 156 A GLU 157 n 157 GLU 157 A ILE 158 n 158 ILE 158 A LYS 159 n 159 LYS 159 A GLY 160 n 160 GLY 160 A ASN 161 n 161 ASN 161 A MET 162 n 162 MET 162 A SER 163 n 163 SER 163 A GLY 164 n 164 GLY 164 A ASN 165 n 165 ASN 165 A PHE 166 n 166 PHE 166 A THR 167 n 167 THR 167 A TYR 168 n 168 TYR 168 A ILE 169 n 169 ILE 169 A ILE 170 n 170 ILE 170 A ASP 171 n 171 ASP 171 A LYS 172 n 172 LYS 172 A LEU 173 n 173 LEU 173 A ILE 174 n 174 ILE 174 A PRO 175 n 175 PRO 175 A ASN 176 n 176 ASN 176 A THR 177 n 177 THR 177 A ASN 178 n 178 ASN 178 A TYR 179 n 179 TYR 179 A CYS 180 n 180 CYS 180 A VAL 181 n 181 VAL 181 A SER 182 n 182 SER 182 A VAL 183 n 183 VAL 183 A TYR 184 n 184 TYR 184 A LEU 185 n 185 LEU 185 A GLU 186 n 186 GLU 186 A HIS 187 n 187 HIS 187 A SER 188 n 188 SER 188 A ASP 189 n 189 ASP 189 A GLU 190 n 190 GLU 190 A GLN 191 n 191 GLN 191 A ALA 192 n 192 ALA 192 A VAL 193 n 193 VAL 193 A ILE 194 n 194 ILE 194 A LYS 195 n 195 LYS 195 A SER 196 n 196 SER 196 A PRO 197 n 197 PRO 197 A LEU 198 n 198 LEU 198 A LYS 199 n 199 LYS 199 A CYS 200 n 200 CYS 200 A THR 201 n 201 THR 201 A LEU 202 n 202 LEU 202 A LEU 203 n 203 LEU 203 A PRO 204 n 204 PRO 204 A PRO 205 n 205 PRO 205 A GLY 206 n 206 GLY 206 A GLN 207 n 207 GLN 207 A GLU 208 n 208 GLU 208 A SER 209 n 209 SER 209 A GLU 210 n 210 GLU 210 A PHE 211 n 211 PHE 211 A SER 212 n 212 SER 212 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 15 A N LYS 15 A O SER 26 A O SER 26 A N SER 23 A N SER 23 A O LEU 68 A O LEU 68 A O LYS 48 A O LYS 48 A N ILE 45 A N ILE 45 A N LEU 42 A N LEU 42 A O VAL 82 A O VAL 82 A N SER 87 A N SER 87 A O THR 90 A O THR 90 A O LYS 48 A O LYS 48 A N ILE 45 A N ILE 45 A N LEU 42 A N LEU 42 A O VAL 82 A O VAL 82 A N THR 81 A N THR 81 A O HIS 97 A O HIS 97 A N GLU 113 A N GLU 113 A O MET 124 A O MET 124 A O ILE 150 A O ILE 150 A N SER 147 A N SER 147 A N VAL 142 A N VAL 142 A O TYR 184 A O TYR 184 A N VAL 181 A N VAL 181 A O LYS 199 A O LYS 199 1 A ASP 3 45.55 -169.25 1 A ASP 6 -69.85 95.65 1 A TYR 7 -69.89 73.55 1 A GLU 10 174.19 63.83 1 A CYS 12 38.40 34.60 1 A HIS 32 -120.31 -70.34 1 A SER 33 -100.75 -67.99 1 A ASP 51 -111.70 55.51 1 A ASN 57 79.95 -9.29 1 A ASN 60 13.08 75.49 1 A LEU 68 -171.49 88.74 1 A TYR 79 -59.51 88.47 1 A SER 94 -160.52 94.73 1 A ALA 102 -39.78 -33.11 1 A MET 105 28.93 88.43 1 A GLU 108 -158.53 -59.03 1 A PRO 110 -33.66 153.50 1 A ASP 138 -156.83 34.48 1 A GLN 146 -110.00 68.29 1 A LYS 159 -69.81 67.20 1 A MET 162 -93.17 41.48 1 A ASP 171 -110.69 -165.70 1 A PRO 175 -38.70 156.17 1 A ASN 176 64.67 67.96 1 A SER 188 177.79 39.76 1 A ALA 192 -95.21 42.71 1 A PRO 197 -50.21 107.63 1 A LEU 198 -49.87 174.84 1 A PRO 204 -55.44 103.23 1 A GLN 207 -92.27 38.02 1 A GLU 208 -74.65 -159.65 1 A SER 209 -56.92 -166.72 minimized average Average structure of the interferon-binding ectodomain of the human type I interferon receptor 1 N N A LEU 101 A LEU 101 HELX_P A MET 105 A MET 105 1 1 5 A VAL 131 A VAL 131 HELX_P A LEU 135 A LEU 135 5 2 5 disulf 2.033 A CYS 12 A SG CYS 12 1_555 A CYS 95 A SG CYS 95 1_555 disulf 2.032 A CYS 58 A SG CYS 58 1_555 A CYS 66 A SG CYS 66 1_555 disulf 2.035 A CYS 180 A SG CYS 180 1_555 A CYS 200 A SG CYS 200 1_555 IMMUNE SYSTEM immunoglobulin fold, fibronectin fold, two-domain structure, IMMUNE SYSTEM INAR2_HUMAN UNP 1 28 P48551 SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESE 28 237 1N6V 1 210 P48551 A 1 1 210 1 cloning artifact PHE 211 1N6V A P48551 UNP 211 1 cloning artifact SER 212 1N6V A P48551 UNP 212 3 4 4 2 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A THR 13 A THR 13 A LEU 18 A LEU 18 A SER 23 A SER 23 A GLU 28 A GLU 28 A CYS 66 A CYS 66 A LEU 68 A LEU 68 A LYS 48 A LYS 48 A VAL 54 A VAL 54 A TYR 39 A TYR 39 A ILE 45 A ILE 45 A ALA 78 A ALA 78 A SER 87 A SER 87 A THR 90 A THR 90 A THR 91 A THR 91 A LYS 48 A LYS 48 A VAL 54 A VAL 54 A TYR 39 A TYR 39 A ILE 45 A ILE 45 A ALA 78 A ALA 78 A SER 87 A SER 87 A CYS 95 A CYS 95 A TRP 100 A TRP 100 A GLU 111 A GLU 111 A PHE 117 A PHE 117 A HIS 120 A HIS 120 A LYS 126 A LYS 126 A ILE 150 A ILE 150 A HIS 154 A HIS 154 A SER 140 A SER 140 A SER 147 A SER 147 A TYR 179 A TYR 179 A GLU 186 A GLU 186 A LYS 199 A LYS 199 A THR 201 A THR 201